In addition, we illustrated that ICC patients with PNI were accompanied with higher frequency of KRAS mutation and an immune suppressive metastasis prone niche characterized by decreased NK cell, increased neutrophil and elevated expression of immune check points’ ligands. The gene discussed is KRAS; the disease is intrahepatic cholangiocarcinoma.